Latest filing published 25 Nov 2019 for Seres Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Marcus Chapman: trading record in brief
Marcus Chapman appears in our data through filings on Seres Therapeutics, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 1 November 2019 and the latest from 22 November 2019.
On the market, this insider has only sold: 1 sale, €12k in total. Besides market trades, the filings include 1 option exercise.
On 25 November 2019 came the latest disclosure, an option exercise in Seres Therapeutics, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Marcus Chapman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,000 shares0Common StockSEC:0000899243-19-028069:0
- 3,400 shares@ US$3.91100.0% of flowCommon StockSEC:0000899243-19-028069:1
2 of 2 declarations
